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ABSTRACT
Squamous cell carcinoma of the tonsil is one of the most frequent cancers of the oropharynx. The 
escalating rate of tonsil cancer during the last decades is associated with the increase of high risk- 
human papilloma virus (HR-HPV) infections. While the microbiome in oropharyngeal malignant diseases 
has been characterized to some extent, the microbial colonization of HR-HPV-associated tonsil cancer 
remains largely unknown. Using 16S rRNA gene amplicon sequencing, we have characterized the micro-
biome of human palatine tonsil crypts in patients suffering from HR-HPV-associated tonsil cancer in 
comparison to a control cohort of adult sleep apnea patients. We found an increased abundance of the 
phyla Firmicutes and Actinobacteria in tumor patients, whereas the abundance of Spirochetes and 
Synergistetes was significantly higher in the control cohort. Furthermore, the accumulation of several 
genera such as Veillonella, Streptococcus and Prevotella_7 in tonsillar crypts was associated with tonsil 
cancer. In contrast, Fusobacterium, Prevotella and Treponema_2 were enriched in sleep apnea patients. 
Machine learning-based bacterial species analysis indicated that a particular bacterial composition in 
tonsillar crypts is tumor-predictive. Species-specific PCR-based validation in extended patient cohorts 
confirmed that differential abundance of Filifactor alocis and Prevotella melaninogenica is a distinct trait of 
tonsil cancer. This study shows that tonsil cancer patients harbor a characteristic microbiome in the crypt 
environment that differs from the microbiome of sleep apnea patients on all phylogenetic levels. 
Moreover, our analysis indicates that profiling of microbial communities in distinct tonsillar niches 
provides microbiome-based avenues for the diagnosis of tonsil cancer.
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Introduction
Oropharyngeal squamous cell carcinoma is one of the most 
prevalent tumor types within the group of head-and-neck 
cancers.1 The stark rise in the incidence of high risk-human 
papilloma virus (HR-HPV) infections has led to a substantial 
increase of tonsil cancer making the tonsillar environment the 
most common site of oropharyngeal cancer.2,3 HPV preferen-
tially infects keratinocyte progenitors located in the basal layer 
of the tonsillar crypt epithelium.4,5 While most infected indi-
viduals clear the virus within 18 months,6 viral persistence and 
alterations in viral gene expression, along with enhanced pro-
duction of the oncogenes E6 and E7, initiate HPV-mediated 
carcinogenesis.5 Moreover, host resistance factors, cellular 
composition, and the general milieu of particular epithelial 
niches determine the outcome of HPV infection.1,4,7 It is thus 
important to determine whether specific microenvironmental 
conditions in tonsillar crypts are associated with tonsil cancer.
All mucosal surfaces of the human body are colonized by 
a plethora of microbial organisms. Bacterial communities in 
the oral and oropharyngeal regions are particularly complex 
and contain, in addition to the gastrointestinal tract, one of the 
most diverse microbiomes.8,9 Oropharyngeal bacterial com-
munities are dominated by the six major phyla Firmicutes, 
Bacteroidetes, Proteobacteria, Actinobacteria, Spirochetes, and 
Fusobacteria representing 96% of all taxa found in the oral 
cavity including the oropharynx.8,10 Moreover, different oral 
structures and tissues such as the hard and soft palates, sub- 
and supragingival surfaces, teeth, lips, cheeks and tonsils are 
colonized by distinct and dynamically changing microbial 
communities.10–12 Hence, assessment of niche-specific differ-
ences of the oral and oropharyngeal microflora is crucial for 
understanding the role of bacteria in oropharyngeal diseases 
such as tonsil cancer.
The microbiota in human tonsils shows a distinct spatial 
distribution with enrichment of particular bacterial species in 
the lymphoid tissue, whereas other species are found mainly in 
layers adherent to the epithelium.13 However, biased 
approaches using rRNA targeted oligonucleotide probes for 
specific bacterial species13 may introduce a technical bias lead-
ing to overrepresentation of particular bacterial species. In 
contrast, culture-independent molecular profiling based on 
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16S rRNA gene amplicon sequencing revealed only minor 
differences in the bacterial composition when different sam-
pling sites in human tonsils and adenoids were compared.14 
Noteworthy, the majority of studies elaborating on the compo-
sition of the tonsillar microbiome have analyzed tissues from 
pediatric patients.14–21 Tonsil cancer occurs only in adults and 
the few available datasets on the adult microbiome in tonsil 
cancer have not considered the inclusion of control 
cohorts.22,23 Here, we have analyzed the tonsillar crypt micro-
biome from two different patient cohorts. We have enrolled 
patients with HR-HPV-positive squamous cell carcinoma of 
the tonsil and have established a control cohort of adult 
patients with obstructive sleep apnea (OSA). Sampling from 
different tonsillar compartments (epithelial surface, crypts and 
lymphoid tissue parenchyma) in OSA patients revealed 
a homogenous microbial composition in tonsillar niches across 
the oropharynx within individual patients. The microbiome 
composition in tonsillar crypts of tonsil cancer patients was 
significantly different when compared to OSA patients. 
Random forest-based classification of the crypt microbiome 
data and species-specific PCR-based validation of extended 
cohorts revealed that certain bacterial species combinations 
are tumor-predictive. In sum, the data presented here suggest 
that the analysis of bacterial communities in tonsillar crypts 
and the elaboration of tumor-predictive bacterial species pat-
tern bear the potential to aid the detection of tonsil cancer.
Results
Tonsillar microbiome diversity in healthy individuals
As a first step for the assessment of microbial alterations in 
tonsil cancer, we have analyzed the tonsillar microbiome of 
a well-defined control cohort of patients that underwent ton-
sillectomy due to OSA. In total, 21 OSA patients were enrolled 
between May 2017 and May 2020. 16S rRNA gene amplicon 
sequencing has been performed on the samples of the first 14 
recruited patients (Table 1), while recruitment continued to 
reach the final cohort size (Supplementary Table 1). To assess 
whether the crypt microbiome represents the global tonsillar 
bacterial composition, we acquired two punch biopsies each 
from the surface epithelium, the lymphoid tissue parenchyma 
and the crypts (Figure 1a). Data from the same patient and 
sampling site were regarded as technical replicates and were 
merged in downstream bioinformatics analyses. In total, 160 
biopsies have been analyzed in the OSA cohort with 130 
samples remaining after quality control. We found a uniform 
within-sample (α-)diversity across different collection sites 
with the mean number of observed species and Chao1 species 
richness estimators showing no significant differences between 
the three sampling sites (Figure 1b). Likewise, both Shannon 
and Simpson indices, which denote species richness and even-
ness, were not significantly different (Figure 1c). Principle 
coordinate analysis using Bray-Curtis (Figure 1d), UNIFRAC 
(Figure 1e) and weighted UNIFRAC (Figure 1f) distance 
metrics did not reveal significant differences in β-diversity 
between the tonsillar compartments. Bacteroidetes, 
Fusobacteria, and Firmicutes were the dominant phyla in the 
three different anatomical locations (Figure 1g). The abun-
dance of the various phyla did not vary significantly between 
the sampling sites suggesting that microbial colonization 
occurs in a homogenous fashion across the different tonsillar 
niches.
To further assess to what extent microbial community 
composition in tonsillar niches of individual patients is con-
served, we compared the microbiome in ipsi- and contralateral 
tonsils of OSA patients (Figure 2a). Wilcoxon signed-rank 
testing did not indicate significant differences in species rich-
ness (Figure 2b) or richness and evenness (Figure 2c) in the 
microbiome of opposing tonsils. Analysis of β-diversity 
revealed a significant dissimilarity for paired PERMANOVA 
testing based on the Bray-Curtis distance (p = .0275) 
(Figure 2d), but not for UNIFRAC (Figure 2e) or weighted 
UNIFRAC distances (Figure 2f). The assessment of individual 
patients in these analyses highlights the substantially higher 
variance between individual patients compared to the differ-
ences between ipsi- and contralateral tonsils (Figure 2d-f). In 
sum, these data indicate that tonsils of OSA patients harbor 
diverse bacterial communities and that the microbial composi-
tion in tonsillar niches of individual patients is similar across 
the oropharynx.
Tonsillar crypt microbiome composition in tonsil 
cancer
Tissue biopsies of 18 patients suffering from squamous cell 
carcinoma of the tonsil have been analyzed by 16S rRNA 
gene amplicon sequencing with almost 90% of the patients 
being HR-HPV-positive (Table 1). In addition to the HPV- 
status, age, sex, TNM tumor staging, nicotine and alcohol 
exposure and secondary carcinomas were documented 
(Supplementary Table 2). Two punch biopsies from the con-
tralateral crypt were collected during the surgery and were 
included in the analysis (Figure 3a). The assessment of four α- 
diversity metrics did not reveal statistically significant differ-
ences between the crypt microbiome of tumor-affected and 
contralateral tonsils (Figure 3b and c). Principle coordinate 
analysis using Bray-Curtis, UNIFRAC and weighted 
UNIFRAC estimators did not indicate statistically significant 
dissimilarities in the microbial community composition of 
tumor-affected vs. contralateral tonsils (Figure 3d-f). 
Extended analyses indicated that the severity of the disease 
here assessed as pathological tumor stage, had a significant 
effect on the β-diversity of the microbial communities in 
tumor patients (Supplementary Figure 1a-c). At phylum level, 
Table 1. Characteristics of patients with 16S rRNA gene amplicon-based analysis 


















14 38.9 ± 11.5 13:1 0/14 0/14
2 SCC of the 
tonsil
18 66.9 ± 12.8 2.6:1 16/18 14/16b
aMain clinical diagnosis as documented in the patient information system; SCC, 
squamous cell carcinoma. 
bData of two patients could not be obtained.
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tumor-affected tonsils exhibited elevated (p = .056) relative 
abundance of Firmicutes (Figure 3g). The genera 
Fusobacterium, Prevotella, Prevoella_7 and Veillonella dis-
played the highest relative abundance in tonsillar crypts of 
tumor patients (Figure 3h). These data are indicative of 
a rather homogenous microbial colonization of the tonsillar 
crypts across the oropharynx in tumor patients; a finding that 
is in line with the results from OSA patients (Figure 2).
Distinct tonsillar crypt microbiome composition in 
tonsil cancer
Next, we compared the crypt microbiome of ipsi- and contral-
ateral tonsils of tumor patient with the crypt microbiome of 
OSA patients. α-diversity measures revealed equal richness 
(Figure 4a) and richness and evenness (Figure 4b) in the 
microbial communities. In contrast, principle coordinate ana-
lysis revealed a significant shift of the microbiome composition 
in tumor patients compared to OSA patients for all distance 
metrics (Figure 4c-e and Supplementary Figure 2a-c). In parti-
cular, we found a substantial dissimilarity in the microbial 
composition on the phylum level with significantly elevated 
abundance of Firmicutes and Actinobacteria and significantly 
reduced abundance of Spirochetes, Synergistetes and 
Fusobacteria in tumor patients (Figure 4f and Supplementary 
Figure 2d). These results were further corroborated using pro-
jection of taxa abundance onto the phylogenetic tree. As shown 
in Supplementary Figure 3, consistent patterns emerged along 
tree branches with significant differences between tumor and 
OSA patients and substantially higher abundance of the phy-
lum Firmicutes and its genera Veillonella, Streptococcus and 
Megasphaera in tumor patients. The microbial composition 
analysis on the genus level revealed differential abundance of 
several genera in tonsillar crypts of tumor vs. OSA patients 
(Figure 4g and Supplementary Figure 4). Fusobacterium was 
the most abundant in OSA tonsils, whereas Veillonella and 
Prevotella_7 were highly abundant in tumor tonsils 
(Figure 4g). The crypt microbiome of contralateral tonsils of 
tumor patients consistently showed an intermediate relative 
abundance on the genus level (Figure 4g and Supplementary 
Figure 4a). The observed shift in relative genera abundance was 
coherent across patients in both cohorts (Supplementary 
Figure 1. Microbiome diversity in different tonsillar compartments of obstructive sleep apnea patients. (a) Schematic representation of the human palatine 
tonsil. The different sampling sites within the tonsil are indicated in gray (crypt), dark blue (epithelium) and bright blue (lymphoid tissue). (b-c) α-diversity in different 
sampling sites of OSA patients (n = 14 patients, only crypt samples have been available for patient 1). (b) Species richness measured in terms of observed number of 
species and Chao1 index. (c) Shannon and Simpson indices estimating species richness and evenness. (d-f) Principle coordinate analysis of the tonsillar microbiome in 
distinct sampling sites calculated using Bray–Curtis (d), UNIFRAC (e) and weighted UNIFRAC (f) distance metrics. Dots represent crypt, epithelial and lymphoid tissue 
biopsies of individual patients (n = 14 patients). Dotted circles represent superimposed normal probability over datapoints. (g) Bacterial community composition in 
different sampling locations of OSA patients at the phylum level. Statistical analysis does not reach significance (p < .05). Statistical analysis was performed using 
Kruskal–Wallis (b-c, g) or PERMANOVA (d-f) tests.
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Figure 4b). The analysis of patient metadata revealed that 
tumor-specific changes were independent of sex 
(Supplementary Figure 5a-c), alcohol consumption (data not 
shown) and smoking habits (Supplementary Figure 5d-g). 
Principle coordinate analysis did not indicate compositional 
dissimilarity based on smoking status (Supplementary 
Figure 5d-g). A highly similar microbial composition could 
be observed on the phylum level in smokers and non-smokers 
(Supplementary Figure 5g). Together, these data unveil 
a distinct tonsillar crypt microbiome composition in patients 
suffering from tonsil cancer.
Identification of tonsil cancer patients based on 
predictive microbiome pattern
To further elaborate a potential relationship between the micro-
biota and tonsil cancer, we compared the crypt microbiome of 
tumor-affected and OSA tonsils at the species level using highly 
resolved taxonomic classification based on the human oral 
microbiome database.24 Since bacterial operational taxonomic 
units typically do not follow a Gaussian distribution, differences 
on the species level were assessed using the DESeq2 method,25 
which permits the analysis of count data based on the negative 
binomial distribution. The heatmap shown in Figure 5a lists the 
top 45 differentially abundant bacterial species in a pattern that 
clearly separates tumor from OSA patients. To assess whether 
the abundance of certain bacterial species in tumor tonsils could 
be used as a predictor for the presence of tonsil cancer, we 
trained a machine-learning algorithm using the available data 
from OSA and tonsil cancer patients. The applied random forest 
classification method was shown previously to outperform other 
supervised classifiers on microbiome data.26 Based on the com-
plete 16S rRNA gene amplicon datasets from tumor and OSA 
patients, the trained model was able to detect a tumor-affected 
patient with high accuracy (0.89), sensitivity (0.89) and specifi-
city (0.88) (Figure 5b). The top ten tumor-predictive species 
included Treponema denticola, Fusobacterium periodonticum, 
Filifactor alocis, Fusobacterium nucleatum subsp.vincentii, 
Megasphaera micronuciformis, Prevotella melaninogenica and 
Veillonella atypica (Figure 5b), which showed all significantly 
different abundances in tumor vs. OSA patients (Figure 5c). To 
validate these results, we performed quantitative PCR analysis 
using biopsy DNA and published primers that allow for the 
reliable detection of bacterial species. For the ten potentially 
Figure 2. Microbial composition in ipsi- and contralateral tonsils of patients with obstructive sleep apnea. (a) Schematic representation of the oropharynx 
representing samples collected from right (dark blue) and left (bright blue) tonsils. (b-c) α-diversity displayed by observed number of species and Chao1 indices (b) and 
Shannon and Simpson indices (c). Dots represent crypt, epithelial and lymphoid tissue biopsies of individual patients (n = 14 patients). (d-f) Principle coordinate analysis 
calculated using Bray–Curtis (d), UNIFRAC (e) and weighted UNIFRAC (f) distance metrics. Samples of each patient are displayed by a distinct color. Dotted circles 
represent superimposed normal probability over data points. Statistical analysis was performed using Wilcoxon signed-rank test (b-c) or paired PERMANOVA (d-f) test.
e1945202-4 A. DE MARTIN ET AL.
predictive bacterial species, the published 16S rRNA gene PCR 
primers for F. alocis27 and P. melaninogenica28 produced the 
most robust abundance measures. Using crypt DNA samples 
from the extended cohorts (21 OSA patients and 28 tonsil 
tumor patients, Supplementary Tables 1 and 2), we found 
a significantly higher relative abundance of F. alocis in crypt 
biopsies of OSA compared to tumor patients (Figure 5d). As 
expected from the random forest analysis, P. melaninogenica 
could be detected by PCR in all samples with significantly 
higher relative abundance in tumor-affected tonsils compared 
to OSA tonsils (Figure 5e). Collectively, these data reveal that 
the assessment of the composition of microbial communities in 
tonsillar crypts can serve as diagnostic means for the detection 
of tonsil cancer.
Discussion
According to the recent WHO classification, tonsillar squa-
mous cell carcinomas are now subdivided into distinct 
Figure 3. The tonsillar microbiome composition in tonsil cancer patients. (a) Schematic representation of the oropharynx illustrating crypt biopsies collected from 
tumor-affected and non-affected contralateral tonsils. (b-c) Comparison of α-diversity between tumor-affected and contralateral tonsils. Observed number of species, 
Chao1, Simpson and Shannon indices are shown. (d-f) Principle coordinate analysis using Bray–Curtis (d), UNIFRAC (e) and weighted UNIFRAC (f) distance metrics. 
Dotted circles represent superimposed normal probability over data points. (g) Taxonomic characterization of the microbiome in tonsil cancer patients on the phylum 
level. Statistical analysis does not reach significance (p < .05). (h) Relative abundance of the top eight highest abundant genera detected in tumor and contralateral 
tonsils. Statistical analysis was performed using Wilcoxon-Mann-Whitney test (b-c, g-h) or PERMANOVA test (d-f).
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morphological groups with HPV-positive cancer arising from 
the tonsillar crypts and exhibiting a non-keratinizing 
morphology.29 The tonsil cancer patients recruited in this 
study suffered from squamous cell carcinoma and the majority 
of the patients showed infection with the high-risk strain 
HPV16, which is consistent with the global pattern.30 Since 
the oral cavity and the oropharynx provide heterogeneous 
niches for bacterial colonization, we have focused on the 
microbiome in tonsillar crypts as the most critical region for 
HPV-induced carcinogenesis. Since the tonsillar microbiome 
in tonsil tumor patients was significantly different from the 
microbiome of adult sleep apnea patients on all phylogenetic 
levels, we conclude that HPV-induced carcinogenesis pro-
foundly alters the conditions for bacterial growth in tonsillar 
crypts. It appears that the dysbiosis in tumor tonsils diffused to 
the contralateral, non-affected tonsils. Our data thus 
Figure 4. Comparison of the crypt microbiome in tonsil cancer and obstructive sleep apnea (OSA) patients. (a-b) α-diversity in crypt biopsies of OSA and tonsil 
cancer patients with (a) species richness assessed by the observed number of species and Chao1 index and (b) Shannon and Simpson indices indicating species richness 
and evenness. (c-e) Principle coordinate analysis using Bray–Curtis (c), UNIFRAC (d) and weighted UNIFRAC (e) distance metrics. Dotted circles represent superimposed 
normal probability over data points. (f) Bacterial community composition in tumor and OSA patient samples on the phylum level. Significant p-values from the statistical 
analysis are indicated. (g) Comparison of the top eight genera with the highest overall relative abundance. Statistical analysis was performed using Kruskall-Wallis (a-b, 
f), PERMANOVA test (c–e), or Wilcoxon-Mann-Whitney test (g) with *, p < .05; **, p < .01; ***, p < .001; ns, not significant.
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suggest that bacterial communities change and adapt to altered 
conditions in the tonsillar environment due to the tumor 
growth and that these changes exert a dominant effect on the 
oropharyngeal microbiome in remote locations.
Localized chronic inflammation is thought to be one of 
the major drivers of carcinogenesis.31 The Gram-negative 
and invasive bacteria Fusobacterium (F.) nucleatum and 
Porphyromonas (P.) gingivalis are frequently discussed to 
Figure 5. Characterization of tonsil cancer and obstructive sleep apnea (OSA) patient microbiomes at species level. (a) Heatmap showing top 45 differentially 
abundant species in crypts of tumor patients compared to OSA patients. (b) Mean decrease in accuracy of top ten tumor-predictive species calculated by means of 
random forest analysis. Bar color indicates phylum affiliation as used in Figure 4F of respective species. (c) Relative abundance of top ten predictive species plotted for 
tumor-bearing and contralateral tonsils of tumor and OSA patients. (d-e) Species specific quantitative PCR. Relative abundance of F. alocis (d) and P. melaninogenica (e) 
in samples from OSA and tumor patients. Statistical analysis was performed using Wilcoxon-Mann-Whitney test (c-e) with *, p < .05; **, p < .01; ***, p < .001; ns, not 
significant.
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be causally involved in the induction of squamous cell 
carcinoma in the oropharynx.32,33 F. nucleatum and 
P. gingivalis have been shown to promote tumor progres-
sion in an oropharyngeal squamous cell carcinoma mouse 
model34 and F. nucleatum subspecies polymorphum has been 
found to be significantly increased in oral squamous cell 
carcinoma biopsies.35 Moreover, an elevated abundance in 
oral wash and surface swabs of oral squamous cell carci-
noma has been described for the genus Fusobacterium.36,37 
However, in our study with the comparison of HPV- 
associated tonsillar squamous cell carcinoma and sleep 
apnea patient, the abundance of Fusobacterium in crypts 
of tumor tonsils was reduced. Moreover, at the species 
level, we found that an increased abundance of 
F. periodonticum and a decreased abundance of 
F. nucleatum subspecies vincentii were part of the tumor- 
predictive microbiome signature according to the random 
forest analysis. It is conceivable that these partially contra-
dictory results are due to the distinct bacterial colonization 
patterns in the tonsillar crypt microenvironment in 
a diverse array of oral and oropharyngeal cancers.
The particular structure of tonsillar crypts is determined by 
the reticulated lymphoepithelial layer that separates the oro-
pharynx from the underlying lymphoid tissue.38 It is most 
likely that the reticulated epithelium that is interspersed with 
lymphocytes and myeloid cells, favors virus-induced malignant 
transformation due to direct access of the virus to epithelial 
stem cells. Furthermore, it is possible that particular bacteria 
foster the access of HPV particles to the basal epithelial cell 
layer. Indeed, Streptococcus-derived furin like endopeptidases 
have been shown to promote infection of epithelial cells by 
HPV16 pseudovirus suggesting that carcinogenesis could be 
enhanced by particular bacterial products.39 It will be impor-
tant to assess in future studies whether the bacterial species that 
have been identified here can alter the crypt microenvironment 
and thereby change HR-HPV infectivity and carcinoma 
induction.
It is most likely that the composition of bacterial commu-
nities in the tonsillar crypt not only affects tumor growth, but 
that once the carcinogenesis is progressing, the altered micro-
environmental conditions in and around the tumor affect the 
local microbiome. Indeed, in this study tonsillar crypts of 
tumor-affected and contralateral, non-affected tonsils of cancer 
patients harbored highly similar microbial communities. These 
results are in line with the study of Wang et al.23 who found 
more similarities than differences between the overall micro-
biomes from frozen tumor and adjacent normal tissues in 
a heterogeneous patient cohort on head and neck squamous 
cell carcinoma. Moreover, it appears that bacterial commu-
nities change during oral cancer progression in general36 and 
in tonsil cancer as described here. Some overarching trends in 
oral and tonsil cancer-associated microbiome alterations 
emerge: elevated Rothia and lowered Fusobacterium 
abundance,40 elevated Streptococcus and Veillonella,41 reduced 
Porphyromonas.36,42 Clearly, tumor-associated and -predictive 
changes in the microbial composition need to be detailed and 
validated on the species level to facilitate further delineation of 
pathogenic principles and the elaboration of diagnostic 
procedures.
Current conclusions about the association of the micro-
biome with oralpharyngeal cancer have been mainly drawn 
from studies using saliva or oral rinse microbiomes.41,43,44 
Using tonsillar crypt biopsies, our study has identified a set of 
bacterial species that appears to be tonsil cancer-predictive. 
The elevated abundance of P. melaninogenica in tonsil cancer 
is consistent with the heightened presence of this bacterial 
species in saliva of oral cancer patients.45 The latter study of 
Mager et al.45 has used DNA hybridization to detect 40 distinct 
bacterial species in saliva specimen. A later study based on 16S 
rRNA gene amplicon sequencing has found a higher abun-
dance of F. nucleatum subspecies polymorphum and 
Porphyromonas aeruginosa in archived frozen tissue of oral 
squamous cell carcinoma patients, whereas bacterial species 
such as Streptococcus mitis, Rothia mucilaginosa and 
Haemophilus parainfluenzae were more frequent in epithelial 
swabs of healthy controls.35 These previous studies, together 
with the data presented here indicate that the assessment of 
bacterial dysbiosis with the quantification of differentially 
abundant bacterial “indicator” species could guide the diagno-
sis of oropharyngeal malignancies. Clearly, future studies will 
be required to further validate the set of bacterial species for 
diagnosis of tonsil cancer elaborated here and to define niche- 
specific microbiome alterations in other oropharyngeal cancer 
entities.
Conclusions
The incidence of HR-HPV-associated tonsil cancer has 
been steadily increasing in the recent decades. The compar-
ison of the tonsillar crypt microbiome of patients suffering 
from tonsil cancer with an OSA patient control cohort 
shows that the microbial ecosystem in the crypt environ-
ment changes during cancer development. Characteristic 
changes in the microbial composition could be detected 
on all phylogenetic levels. Machine learning-based analysis 
of the 16S rRNA gene amplicon sequencing data and PCR- 
based validation indicated that particular bacterial species 
combinations in the tonsillar crypt microenvironment can 
aid the diagnosis of tonsil cancer.
Methods
Study population and sample collection
The study protocol has been reviewed and approved by the 
Ethikkommission Ostschweiz (EKOS), permission number 
2017–00051. All study participants provided written informed 
consent in accordance with the Declaration of Helsinki and the 
International Conference on Harmonization Guidelines for 
Good Clinical Practice. All regulations were followed accord-
ing to the Swiss authorities and according to the clinical pro-
tocols. The sample size calculation for the study was not 
performed because of the exploratory nature of the study 
design.
Patients suffering from obstructive sleep apnea (OSA) were 
prospectively enrolled in control cohort 1 with a total of 21 
participants that underwent tonsillectomy between May 2017 
and May 2020. Exclusion criteria were as follows: (a) acute or 
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chronic tonsillitis, (b) any disease with immunosuppression, 
(c) immunosuppressive treatment, and (d) intake of antibiotics 
up to 4 weeks before surgery. After excision, tonsils were 
placed on a sterile surface and 4 mm punch biopsies (Stiefel® 
Biopsy punch) were taken using a sterile single-use stainless- 
steel instrument immediately in the operation theater using 
separate sterile pairs of scissors and forceps to avoid cross- 
contamination between samples. Two biopsies were punched 
out of the tonsil surface epithelium and two biopsies were 
taken from tonsillar crypts. Next, tonsils were cut in half with 
a sterile surgical blade and two lymphoid tissue samples were 
harvested by punch biopsy.
Patients diagnosed with a primary, untreated and histologi-
cally confirmed squamous cell carcinoma of the tonsil (n = 28) 
were prospectively included into the study cohort 2 between 
August 2017 and February 2020. Patients with previous radio-
therapy or surgery due to oropharyngeal cancer were excluded. 
Two punch biopsies from tonsillar crypts were taken directly 
after removal of the tumor-affected tonsil and two crypt biop-
sies were acquired from the contralateral tonsil during surgery. 
In cases when tumor tonsils were not resected, crypt biopsies 
were acquired in situ by punch biopsy. Each biopsy was 
acquired using a fresh sterile biopsy punch and a separate 
sterile pair of scissors and forceps. Tissue biopsies were placed 
in sterile tubes on ice and stored at −80°C within 30 min until 
further analysis.
DNA extraction and 16S rRNA gene amplicon 
sequencing
Bacterial genomic DNA was extracted and purified using 
QIAamp DNA Stool Mini Kit (Qiagen) with minor mod-
ifications. Lysing Matrix D tubes (MPBio) were used for 
tissue disruption and an additional extraction step was 
introduced after incubation of bacteria with a lysis buffer 
(20 mg/ml lysozyme – Sigma 62970–5 G-F, 2 mM EDTA, 
1.2% Triton, 20 mM Tris-HCL) for an optimal yield of 
bacterial DNA. PCR amplification of the V4 region of 
bacterial 16S rRNA gene was performed with barcoded 
primers following a dual-index paired-end sequencing 
approach.46 PCR was performed using KAPA HiFi poly-
merase (Roche) under the following cycling conditions: 
initial denaturation at 98°C (2 min), 25–40 cycles of 
98°C (30 sec), 55°C (30 sec), 72°C (20 sec) and final 
elongation at 72°C (7 min). PCR products including 
a negative control were electrophoresed on a 1% agarose 
gel to ensure high-fidelity amplification. NucleoMag® NGS 
(Macherey-Nagel) was used for PCR clean up and size 
selection. Individual libraries were normalized with 
SequalPrep™ Normalization Plate Kit (ThermoFisher) 
according to the manufacturer’s instruction and combined 
into a pooled library. The combined library was qualita-
tively and quantitatively assessed with a High Sensitivity 
D1000 ScreenTape device (Agilent) and on a Qubit fluo-
rometer (ThermoFisher). 16S rRNA V4 amplicon sequen-
cing was performed on the Illumina MiSeq v2 platform. 
Miseq data was converted to fastq format and demulti-
plexed using bcl2fastq software (Illumina).
Read processing and taxonomic analysis
Cutadapt was used for quality trimming and removal of the 
primer and adaptor sequences.47 Further processing and 
analysis were run in R version 3.6.1. Trimmed reads were 
filtered and truncated based on quality scores and read 
length using the R/bioconductor package dada2 v1.14.048 
with 230 bp as length for forward reads and 210 bp for 
reverse reads. After dereplication error rates were estimated 
based on a parametric error model as implemented in the 
dada2 package and sequence variants were generated using 
the ‘dada’ function. Chimeric reads were removed using the 
‘removeBimeraDenovo’ function. Finally, taxonomy was 
assigned based on the RDP trainset 16/release 11.549 and 
the HOMD v.15.124 database by applying the 
‚assignTaxonomy’ function from the dada2 package that 
utilizes the RDP Naive Bayesian Classifier described by 
Wang et al,50 with kmer size = 8, and 100 bootstrap 
replicates. In order to further infer phylogenetic relation-
ships R/bioconductor packages msa v.1.18.051 and phan-
gorn v.2.5.552 were used to build multiple sequence 
alignments and construct a phylogenetic tree. Before down-
stream analysis samples were rarefied to an even sampling 
depth of 500 reads using the R/bioconductor package phy-
loseq v.1.32.0.53 Samples with less than 500 reads were 
removed from further analysis resulting in a final dataset 
of 192 samples. The observed low read counts compared to 
typical feces samples were expected, as the DNA was iso-
lated from tissue biopsies.
Statistical analysis
Rarefied samples were analyzed for alpha diversity based on 
shannon, simpson and inverse simpson metrics and beta 
diversity based on Bray-Curtis, UNIFRAC, and weighted 
UNIFRAC distances. All diversity measures were computed 
running the ‘diversity’ function from the R/Bioconductor 
package vegan v.2.5–754 and Kruskal-Wallis and Wilcoxon 
tests were used to test for significant differences in α- 
diversity measures. β-diversity was visualized by principal 
coordinate analysis and permutational ANOVA was run 
using the ‘adonis’ function from R/bioconductor package 
vegan v.2.5–754 to test for significant differences between 
patient and sample groups. Samples that were collected 
from the same patient and location were regarded as tech-
nical replicates and all statistical tests were run on mean 
values from technical replicates. Differences in relative 
abundances between groups on phylum, family, and genus 
level were tested using Kruskal–Wallis and Wilcoxon-Mann 
-Whitney tests to compute statistics. In order to further 
examine the hierarchical relationship of taxa with differ-
ences in their relative abundance, a tree-based visualization 
technique was used by running the ‘heat_tree’ function 
from the metacoder R packages v.0.3.3.55 Finally, differen-
tially abundant taxa between groups were identified utiliz-
ing the Bioconductor packages phyloseq v.1.32.053 and 
DESeq2 v.1.28.125 following standard protocols for differ-
ential abundance analysis. Statistical analyses of quantitative 
PCR data were performed with Prism 8.4.3 (GraphPad). 
ONCOIMMUNOLOGY e1945202-9
Graphs depict mean ± s.d. and differences between two 
groups were evaluated using Wilcoxon-Mann-Whitney 
tests. Results were considered statistically significant 
with p < .05.
Random forest analysis
Random Forest analysis was performed on species abundance 
data from control and tumor crypt samples using the 
randomForest R package v.4.6–14.56 Data pre-processing 
included removal of rare OTUs based on mean relative abun-
dances followed by re-normalization and scaling of the remain-
ing 405 OTUs. The random forest model was fitted by running 
the ‘randomForest’ function with ntree = 5001 and default 
values for mtry. Model significance was assessed by running 
the ‘rf.significance’ function from the rfUtilities R package 
v.2.1–557 with 1,000 permutations. Model performance was 
tested by running a leave-one-out cross-validation utilizing 
the ‘train’ function from the caret R package v.6.0–8658 with 
identical mtry and ntree parameters as before. Finally, the 
mean decrease in accuracy (MDA) was computed as 
a measure for the importance of each taxa for the overall 
model and used to rank the taxa.
Quantitative PCR
Extracted DNA was used as a template for bacterial qPCR 
amplification and quantification using a real-time PCR 
machine (Quant Studio 5) and SYBR Green PCR technology 
(Applied Biosystems, Thermo Fisher Scientific). A pair of ubi-
quitous bacterial 16S rDNA-directed primers (forward 5’- 
ACTCCTACGGGAGGCAGCAGT-3’ and reverse 5’- 
ATTACCGCGGCTGCTGGC-3’) was used to assess the total 
amount of bacteria in the samples.59 Cycling conditions have 
included a denaturation step at 95°C for 10 min followed by 30 
cycles of 95°C (10 sec), 63°C (20 sec), and 72°C (20 sec). Using 
the CT-values of eubacteria abundances of F.alocis and P.mel-
aninogenica were calculated. F.alocis was quantified using spe-
cies-specific primers targeting the 16S rRNA gene that have 
been established and validated.27 16S rRNA gene-directed for-
ward 5’-CAG GTG GTT TAA CAA GTT AGT GG-3’ and 
reverse 5’-CTA AGT TGT CCT TAG CTG TCT CG-3’ primers 
and a cycling protocol of denaturation at 95°C (2 min) followed 
by 40 cycles of 95°C (15 sec), 60°C (1 min) and 72°C (1 min) 
were applied. P.melaninogenica specific 16S rRNA gene direc-
ted forward 5’-GTGGGATAACCTGCCGAAAG-3’ and 
reverse 5’-CCCATCCATTACCGATAAATCTTTA-3’ primers 
have been described and tested before.28 The cycling protocol 
used was 95°C (10 min) and 40 cycles of 95°C (15 sec), 60°C 
(1 min) and 72°C (1 min). PCR amplification of each sample 
was performed in duplicates and the 20 ul qPCR mixture 
consisted of 10 ul of 2X SYBR Green MasterMix (Applied 
Biosystems, Thermo Fisher Scientific) 1 ul of each primer, 7 
ul PCR-grade water and 1ul of extracted DNA.
Short summary
Tonsil cancer patients harbor a characteristic tonsillar crypt microbiome 
that is significantly different from the microbiome of adult sleep apnea 
patients on all phylogenetic levels.
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